Correlation Between Pulmatrix and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Protagenic Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Protagenic Therapeutics.
Diversification Opportunities for Pulmatrix and Protagenic Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pulmatrix and Protagenic is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Pulmatrix and Protagenic Therapeutics
Given the investment horizon of 90 days Pulmatrix is expected to generate 1.95 times more return on investment than Protagenic Therapeutics. However, Pulmatrix is 1.95 times more volatile than Protagenic Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 218.00 in Pulmatrix on August 30, 2024 and sell it today you would earn a total of 516.00 from holding Pulmatrix or generate 236.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pulmatrix vs. Protagenic Therapeutics
Performance |
| Timeline |
| Pulmatrix |
| Protagenic Therapeutics |
Pulmatrix and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pulmatrix and Protagenic Therapeutics
The main advantage of trading using opposite Pulmatrix and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |